A Novel Microfluidic Assay for Rapid Phenotypic Antibiotic Susceptibility Testing of Bacteria Detected in Clinical Blood Cultures

Time lapse investigation of antibiotic susceptibility using a microfluidic linear gradient 3D culture device

(2014) Zining Hou et al.   LAB ON A CHIP

Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012

(2013) R. P. Dellinger et al.   INTENSIVE CARE MEDICINE

Progress on the development of rapid methods for antimicrobial susceptibility testing

(2013) M. R. Pulido et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Next-Generation Antimicrobial Susceptibility Testing

(2013) A. van Belkum et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Antibiotic resistance—the need for global solutions

(2013) Ramanan Laxminarayan et al.   LANCET INFECTIOUS DISEASES

Systematic Review and Meta-Analysis of the Significance of Heterogeneous Vancomycin-IntermediateStaphylococcus aureusIsolates

(2010) Sebastiaan J. van Hal et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activity of telavancin against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) in vitro and in an in vivo mouse model of bacteraemia

(2010) S. S. Hegde et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Vancomycin Heteroresistance and Methicillin-ResistantStaphylococcus aureus

(2009) Stan Deresinski   JOURNAL OF INFECTIOUS DISEASES

Vancomycin MICs for Methicillin-Resistant Staphylococcus aureus Isolates Differ Based upon the Susceptibility Test Method Used

(2008) V. Prakash et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY